ADVERTISEMENT
Posted: Jun 7, 2024

Court upholds student pharmacist dismissal for failed APPE courses

On The Docket

Student pharmacists can be dismissed from their pharmacy program for a variety of reasons, including poor academic performance and academic dishonesty. Most dismissals are relatively easy to support based on objective evidence. The dismissal of a student pharmacist for lack of clinical skills and for unprofessional conduct during APPE courses is more subjective and is more difficult to justify.

David B. Brushwood, BSPharm, JD

Read more
Posted: Jun 7, 2024

Pharmacists share strategies for hiring—and retaining—pharmacy technicians

Pharmacy Techs

“How do I find good pharmacy technicians? How do I hold onto them?” These are the questions on a lot of pharmacists’ minds today. Technician turnover is at an all-time high and pharmacies are struggling to fill pharmacy technician positions.

Loren Bonner

Read more
Posted: Jun 7, 2024

Without access to Flovent, the youngest patients face challenges

Pediatric Asthma

In January 2024, GSK discontinued sales of its Flovent HFA and Flovent Diskus inhalers. The company attributed the change to the availability of generic alternatives that work just as well but for a potentially lower price. However, few insurance companies cover the authorized generics, leading to serious challenges in finding an acceptable replacement for the drug, particularly for parents of some small children.

Sonya Collins

Read more
Posted: Jun 7, 2024

Burden of Change Healthcare cyberattack fell on pharmacists. But it shouldn’t have.

On The Cover

When the Change Healthcare cyberattack occurred on February 21, 2024, pharmacy staff at Moose Pharmacy of Monroe in North Carolina initially thought insurance processing was down.

Loren Bonner & Corey Diamond, PharmD

Read more
Posted: May 7, 2024

Ready or not, psychedelic medicine is coming to market

On The Cover

In February, FDA accepted Lykos Therapeutics’ new drug application (NDA) for midomafetamine (MDMA) capsules, used in combination with psychotherapy, for the treatment of PTSD. If the treatment is approved, a decision that could come as soon as August 2024, it will be the first in what is expected to be a growing number of FDA-approved psychedelic-assisted therapies.

Sonya Collins

Read more
First1415161719212223Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT